GALT earnings
Galectin Therapeutics (GALT) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- GALT beat EPS estimates in 9 of its last 17 reports.
GALT earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 16, 2026 | -0.04 | -0.05 | 20.00% | – |
| Q2 2026 | Aug 14, 2026 | -0.14 | -0.09 | -55.56% | – |
| Q1 2026 | May 15, 2026 | -0.08 | -0.06 | -33.33% | – |
| Q4 2025 | Mar 31, 2026 | -0.08 | -0.10 | 20.00% | – |
| Q3 2025 | Nov 14, 2025 | -0.13 | -0.11 | -18.18% | – |
| Q2 2025 | Aug 14, 2025 | -0.12 | -0.16 | 25.00% | – |
| Q1 2025 | May 15, 2025 | -0.15 | -0.20 | 25.00% | – |
| Q4 2024 | Mar 31, 2025 | -0.19 | -0.16 | -18.75% | $36.00K |
| Q3 2024 | Nov 14, 2024 | -0.18 | -0.20 | 10.00% | – |
| Q2 2024 | Aug 13, 2024 | -0.20 | -0.16 | -25.00% | – |
| Q1 2024 | May 15, 2024 | -0.19 | -0.16 | -18.75% | – |
| Q4 2023 | Mar 29, 2024 | -0.16 | -0.16 | 0.00% | $80.00K |
| Q3 2023 | Nov 13, 2023 | -0.24 | -0.16 | -50.00% | – |
| Q2 2023 | Aug 14, 2023 | -0.15 | -0.21 | 28.57% | – |
| Q1 2023 | May 15, 2023 | -0.19 | -0.21 | 9.52% | – |
| Q4 2022 | Mar 30, 2023 | -0.18 | -0.17 | -5.88% | – |
| Q3 2022 | Nov 14, 2022 | -0.14 | -0.20 | 30.00% | – |